Investigation the Effect of Covid-19 Fear, Anxiety on Daily Life, Sleep Quality, and Anxiety-depression of the Patients With Fibromyalgia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fibromyalgia
- Sponsor
- Diskapi Yildirim Beyazit Education and Research Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Level of Covid-19 anxiety
- Last Updated
- 5 years ago
Overview
Brief Summary
The investigators planned to analyze the effect of Covid-19 fear and anxiety on the daily life, sleep quality and depression-anxiety levels of fibromyalgia patients.
Detailed Description
Fibromyalgia; as a chronic syndrome of unknown cause with widespread body pain, fatigue, sleep disorder, cognitive impairment and anxiety. Many studies have shown a relationship between pain levels and anxiety levels in patients with fibromyalgia. Covid-19 started from Wuhan, China in December 2019 and spread worldwide. The rapid spread of this unexpected pandemic all over the world brought with it many conditions such as anxiety and stress disorders. It has been reported by experts that individuals with a predisposition to conditions such as anxiety and stress disorder in premorbidity require special attention.To evaluate the psychological effects of the Covid-19 pandemic, the Covid-19 anxiety scale was developed from Lee et al. and the Covid-19 fear scale was developed from Ahoursou et al. The investigators planned to analyzed the effect on Covid-19 fear and anxiety level on fibromyalgia patients' daily life with revised Fibromyalgia Impact questionnaire, sleep quality with Pittsburgh Sleep Quality Index, and anxiety-depression level with The Hospital Anxiety and Depression scale. This study was planned as a cross-sectional case control study.
Investigators
Damla Cankurtaran
Medical doctor
Diskapi Yildirim Beyazit Education and Research Hospital
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with having other modd disorders
- •Patients with severe musculoskeletal diseases
- •Patients with other rheumatologic diseases
Outcomes
Primary Outcomes
Level of Covid-19 anxiety
Time Frame: 15 seconds
It is evaluated by the Coronavirus anxiety scale (CAS). It was developed by Lee et al. and Evren et al. were made validity and reliability of this scale in Turkish. It is 5-items scale, and each item scores between 0-4. The total score (ranging from 0 to 20) is calculated by adding up each item score. The higher the score, the greater the anxiety associated with coronavirus-19. Level of Covid-19 anxiety will be compared between fibromyalgia and control groups.
Level of Covid-19 fear
Time Frame: 15 seconds
It is evaluated with The Fear Covid-19 Scale which was developed by Ahorsu et al., and it was adapted into Turkish. It is 7-item scale, each item scores with 5-pont Likert scale. Total score is 35, and the higher score describe higher fear level. Level of Covid-19 fear will be compared between fibromyalgia and control groups.
Secondary Outcomes
- The Covid-19 anxiety and fear levels on sleep quality the patients with fibromyalgia(15 seconds)
- The Covid-19 anxiety and fear levels on daily life the patients with fibromyalgia(15 seconds)
- The Covid-19 anxiety and fear levels on anxiety-depression the patients with fibromyalgia(15 seconds)